These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36585760)

  • 1. Multiple keratoacanthomas induced by treatment with dasatinib and bosutinib for chronic myeloid leukemia: A case report and literature review.
    Kosaka K; Yasuda M; Kim J; Saito S; Uehara A; Handa H; Motegi SI
    J Dermatol; 2023 May; 50(5):e171-e172. PubMed ID: 36585760
    [No Abstract]   [Full Text] [Related]  

  • 2. Dasatinib-induced Chylothorax in Chronic Myelogenous Leukemia in Pediatric Patient: Report of a Case and Review of Literature.
    Hickman K; Diaz E; Graham R; Adams R; Ngwube A
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):e665-e667. PubMed ID: 31688632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib.
    Takekoshi D; Matsui Y; Akutsu T; Nishioka A; Kiritani A; Okuda K; Watanabe J; Miyagawa H; Utsumi H; Hashimoto M; Wakui H; Minagawa S; Hara H; Numata T; Noda Y; Makishima R; Ikegami M; Kawabata Y; Araya J; Kuwano K
    Intern Med; 2020 Sep; 59(18):2297-2300. PubMed ID: 32536651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia.
    Muresan B; Mamolo C; Cappelleri JC; Leip E; Viqueira A; Heeg B
    Curr Med Res Opin; 2021 May; 37(5):801-809. PubMed ID: 33733983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia.
    Inoue H; Taji H; Yamada K; Iriyama C; Saito T; Kato H; Yanada M; Yamamoto K; Matsukawa N
    Intern Med; 2020 Oct; 59(19):2419-2421. PubMed ID: 32611965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Hepatotoxicity Associated With New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients With Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis.
    Wang Z; Wang X; Wang Z; Feng Y; Jia Y; Jiang L; Xia Y; Cao J; Liu Y
    JAMA Netw Open; 2021 Jul; 4(7):e2120165. PubMed ID: 34292334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European medicines agency review of bosutinib for the treatment of adult patients with chronic myelogenous leukemia: summary of the scientific assessment of the committee for medicinal products for human use.
    Hanaizi Z; Unkrig C; Enzmann H; Camarero J; Sancho-Lopez A; Salmonson T; Gisselbrecht C; Laane E; Pignatti F
    Oncologist; 2014 Apr; 19(4):421-5. PubMed ID: 24668331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of bosutinib in chronic phase CML patients developing pleural effusion under dasatinib therapy.
    Tiribelli M; Abruzzese E; Capodanno I; Sorà F; Trabacchi E; Iurlo A; Luciano L; Binotto G; Bonifacio M; Annunziata M; Crugnola M; Fanin R
    Ann Hematol; 2019 Nov; 98(11):2609-2611. PubMed ID: 31529281
    [No Abstract]   [Full Text] [Related]  

  • 9. Dasatinib-induced Chylothorax in Chronic Myeloid Leukemia.
    Alqattan Y; Ali S; Almohammad R; Kayali N; Alhuraiji A
    Gulf J Oncolog; 2022 Sep; 1(40):74-77. PubMed ID: 36448074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review.
    Bouquet E; Jourdain A; Machet MC; Beau-Salinas F; Jonville-Béra AP
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28439970
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors.
    Weatherald J; Bondeelle L; Chaumais MC; Guignabert C; Savale L; Jaïs X; Sitbon O; Rousselot P; Humbert M; Bergeron A; Montani D
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32527740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dasatinib in the management of chronic myeloid leukemia.
    Chen R; Chen B
    Drug Des Devel Ther; 2015; 9():773-9. PubMed ID: 25709401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sweet syndrome in a patient with chronic myelogenous leukemia under dasatinib treatment.
    Matsuda T; Ueda-Hayakawa I; Kambe N; Fujita S; Okamoto H
    J Dermatol; 2019 Sep; 46(9):e317-e318. PubMed ID: 30932238
    [No Abstract]   [Full Text] [Related]  

  • 15. Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report.
    Ochiai S; Sato Y; Minakawa A; Fukuda A; Fujimoto S
    BMC Nephrol; 2019 Mar; 20(1):87. PubMed ID: 30845905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial pneumonitis associated with dasatinib treatment for chronic myeloid leukemia or acute lymphoblastic leukemia: case series and a literature review.
    Kim SA; Kwon BS; Chung JH; Lee JY; Bang SM; Lee JO
    Ther Adv Respir Dis; 2022; 16():17534666221135322. PubMed ID: 36346055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.
    Cortes JE; Jimenez CA; Mauro MJ; Geyer A; Pinilla-Ibarz J; Smith BD
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):78-82. PubMed ID: 28082112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bosutinib, dasatinib, imatinib, nilotinib, and ponatinib differentially affect the vascular molecular pathways and functionality of human endothelial cells.
    Gover-Proaktor A; Granot G; Pasmanik-Chor M; Pasvolsky O; Shapira S; Raz O; Raanani P; Leader A
    Leuk Lymphoma; 2019 Jan; 60(1):189-199. PubMed ID: 29741440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib-induced panniculitis in a patient with chronic myeloid leukaemia.
    Nagasawa Y; Iinuma S; Fujii M; Kanno K; Honma M; Yuzawa S; Ishida-Yamamoto A
    Eur J Dermatol; 2021 Feb; 31(1):87-88. PubMed ID: 33495146
    [No Abstract]   [Full Text] [Related]  

  • 20. Bosutinib-induced massive pleural effusion: Cross-intolerance with all tyrosine kinase inhibitors.
    Aslan NA; Hıncal HO; Elver Ö; Erol V; Güler N
    J Oncol Pharm Pract; 2023 Mar; 29(2):511-516. PubMed ID: 35821583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.